Author – The Durango Herald

FDA OKs new therapy for some hemophilia patients

TRENTON, N.J – U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia. The Food and Drug Admi...

DATE: Nov 17, 2017 | CATEGORY: Nation & World

FDA approves better vaccine against painful shingles virus

U.S. regulators have approved a new, more effective vaccine to prevent painful shingles, which is caused by the chickenpox virus. Drugmaker GlaxoSmithKline said the Food and Drug ...

DATE: Oct 23, 2017 | CATEGORY: Health

Merck scraps disappointing experimental cholesterol drug

TRENTON, N.J. – Merck has decided to abandon efforts to market a closely watched experimental cholesterol medicine after mediocre test results. Merck’s decision Wednesday to not s...

DATE: Oct 12, 2017 | CATEGORY: Nation & World

Asked to serve, some CEOs say no more to Trump

TRENTON, N.J. – First it was the leader of a major U.S. pharmaceutical, then the CEO of an athletic gear company, and before the day had ended, the chief executive of a $170 billion tech gia...

DATE: Aug 15, 2017 | CATEGORY: Nation & World

Novel leukemia treatment could be 1st U.S. gene therapy

A treatment for a common childhood blood cancer could become the first gene therapy available in the U.S. A Food and Drug Administration advisory panel voted 10-0 on Wednesday in ...

DATE: Jul 15, 2017 | CATEGORY: Health

FDA asks drugmaker to stop selling its opioid painkiller

TRENTON, N.J. – U.S. regulators want a narcotic painkiller involved in the opioid epidemic off the market amid data showing people continue to abuse it. The Food and Drug Administ...

DATE: Jun 10, 2017 | CATEGORY: Health

Tests for lead poisoning may be faulty, U.S. regulators warn

U.S. health agencies on Wednesday warned that certain blood tests for lead poisoning may give results lower than the actual level of lead. As a result, some children under 6, alon...

DATE: May 17, 2017 | CATEGORY: Health

FDA approves 1st drug for aggressive multiple sclerosis

TRENTON, N.J. – U.S. regulators have approved the first drug for an aggressive kind of multiple sclerosis that steadily reduces coordination and the ability to walk. The Food and ...

DATE: Mar 29, 2017 | CATEGORY: Health

FDA approves 1st drug for moderate and severe eczema cases

TRENTON, N.J. – U.S. regulators have approved the first powerful, injected medicine to treat serious cases of the skin condition eczema. The Food and Drug Administration on Tuesda...

DATE: Mar 28, 2017 | CATEGORY: Health

FDA approves 1st drug for moderate & severe eczema cases

TRENTON, N.J. – U.S. regulators have approved the first powerful, injected medicine to treat serious cases of the skin condition eczema. The Food and Drug Administration on Tuesda...

DATE: Mar 28, 2017 | CATEGORY: Nation & World

How EpiPen’s maker raised prices, and hackles

TRENTON, N.J. – Sky-high price hikes for EpiPen, the injected emergency medicine for severe allergic reactions to foods and bug bites, have made its maker the latest target for patients and ...

DATE: Aug 23, 2016 | CATEGORY: Nation & World

Allergan, Pfizer call off proposed $160B merger

The biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to ...

DATE: Apr 6, 2016 | CATEGORY: Nation & World